Viking Therapeutics, Inc. (VKTX)
28.51
+0.78
(+2.81%)
USD |
NASDAQ |
Oct 09, 16:00
28.40
-0.11
(-0.39%)
Pre-Market: 09:27
Viking Therapeutics Free Cash Flow (Quarterly) : -125.17M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -125.17M |
| March 31, 2026 | -113.98M |
| December 31, 2025 | -85.29M |
| September 30, 2025 | -94.00M |
| June 30, 2025 | -47.06M |
| March 31, 2025 | -52.33M |
| December 31, 2024 | -31.18M |
| September 30, 2024 | -21.96M |
| June 30, 2024 | -28.51M |
| March 31, 2024 | -6.134M |
| December 31, 2023 | -17.64M |
| September 30, 2023 | -19.66M |
| June 30, 2023 | -11.44M |
| March 31, 2023 | -24.64M |
| December 31, 2022 | -10.93M |
| September 30, 2022 | -13.50M |
| June 30, 2022 | -13.44M |
| March 31, 2022 | -10.53M |
| December 31, 2021 | -12.35M |
| September 30, 2021 | -10.93M |
| June 30, 2021 | -13.43M |
| March 31, 2021 | -10.88M |
| December 31, 2020 | -5.486M |
| September 30, 2020 | -5.323M |
| June 30, 2020 | -6.666M |
| Date | Value |
|---|---|
| March 31, 2020 | -4.302M |
| December 31, 2019 | -11.74M |
| September 30, 2019 | -3.398M |
| June 30, 2019 | -6.459M |
| March 31, 2019 | -3.152M |
| December 31, 2018 | -2.679M |
| September 30, 2018 | -5.503M |
| June 30, 2018 | -5.27M |
| March 31, 2018 | -5.303M |
| December 31, 2017 | -3.948M |
| September 30, 2017 | -3.328M |
| June 30, 2017 | -4.203M |
| March 31, 2017 | -3.279M |
| December 31, 2016 | -2.465M |
| September 30, 2016 | -2.654M |
| June 30, 2016 | -3.227M |
| March 31, 2016 | -2.725M |
| December 31, 2015 | -3.299M |
| September 30, 2015 | -3.400M |
| June 30, 2015 | -1.621M |
| March 31, 2015 | -0.4109M |
| June 30, 2014 | -0.4374M |
| March 31, 2014 | -0.1008M |
| June 30, 2013 | -0.0099M |
| March 31, 2013 | 0.00 |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Eli Lilly & Co. | 4.475B |
| Regeneron Pharmaceuticals, Inc. | 521.80M |
| Amgen, Inc. | 3.489B |
| Vertex Pharmaceuticals, Inc. | 1.013B |
| Ironwood Pharmaceuticals, Inc. | 58.28M |